Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
28,234,434
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
4,769,266
-
Shares change
-
-720,983
-
Total reported value, excl. options
-
$53,493,964
-
Value change
-
-$12,166,751
-
Put/Call ratio
-
57%
-
Number of buys
-
34
-
Number of sells
-
-34
-
Price
-
$11.22
Significant Holders of ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) as of Q4 2021
89 filings reported holding CLPT - ClearPoint Neuro, Inc. - Common Stock, $0.01 par value as of Q4 2021.
ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,769,266 shares
of 28,234,434 outstanding shares and own 16.89% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,176,355 shares), VANGUARD GROUP INC (925,789 shares), STATE STREET CORP (301,210 shares), GEODE CAPITAL MANAGEMENT, LLC (293,492 shares), Taylor Frigon Capital Management LLC (175,153 shares), NORTHERN TRUST CORP (170,143 shares), TWO SIGMA INVESTMENTS, LP (133,666 shares), MORGAN STANLEY (126,193 shares), PARSONS CAPITAL MANAGEMENT INC/RI (110,322 shares), and GUARDIAN POINT CAPITAL, LP (100,000 shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.